Dr. Faridar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
6560 Fannin Street
Suite 750
Houston, TX 77030Phone+1 713-441-1150Fax+1 713-791-5125- Is this information wrong?
Education & Training
- Methodist Hospital (Houston)Fellowship, Dementia Translational Fellowship, 2017 - 2018
- Methodist Hospital (Houston)Residency, Neurology, 2013 - 2017
- University of California San Francisco School of MedicinePost-Doctoral Fellowship, Neuroscience, 2011 - 2013
- Tehran University of Medical Sciences School of MedicineClass of 2008
Certifications & Licensure
- TX State Medical License 2017 - 2024
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- BrightFocus Alzheimer Disease Research Fellowship Award 2019
- American Neurology Association (ANA) travel award 2013
Clinical Trials
- Phase II Clinical Trial of Interleukin-2 in AD Start of enrollment: 2023 Mar 17
Roles: Contact, Principal Investigator
- Systemic and Central Inflammation in AD Start of enrollment: 2023 Mar 17
Roles: Contact
Publications & Presentations
PubMed
- A phase 1 open-label pilot study of low-dose interleukine-2 immunotherapy in patients with Alzheimer's disease.Alireza Faridar, Abdulmunaim M Eid, Aaron D Thome, Weihua Zhao, David R Beers, Maria B Pascual, Mohammad O Nakawah, Gustavo C Roman, Charles S Davis, Michael Grundman,...> ;Translational Neurodegeneration. 2023 Nov 16
- 14 citationsEx vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer's disease.Alireza Faridar, Matthew Vasquez, Aaron D Thome, Zheng Yin, Hui Xuan, Shixiang Wen, Xuping Li, Jason R Thonhoff, Weihua Zhao, Hong Zhao, David R Beers, Stephen T C Won...> ;Acta Neuropathologica Communications. 2022 Sep 30
- 10 citationsTregs Attenuate Peripheral Oxidative Stress and Acute Phase Proteins in ALS.David R Beers, Jason R Thonhoff, Alireza Faridar, Aaron D Thome, Weihua Zhao, Shixiang Wen, Stanley H Appel> ;Annals of Neurology. 2022 Aug 1
- Join now to see all
Press Mentions
- Coya Therapeutics Reports Data from Alzheimer’s Disease Therapy TrialApril 3rd, 2023
- Coya Therapeutics Presents Biomarker Data on Neuroinflammatory Pathways in Frontotemporal Dementia (FTD) at the AD/PD 2024 ConferenceMarch 7th, 2024
- Coya Therapeutics to Present Data on Immune System and Regulatory T Cell (Treg) Contributions in Frontotemporal Dementia (FTD) Patients at AD/PD 2024 ConferenceMarch 1st, 2024
- Join now to see all
Hospital Affiliations
- Houston Methodist HospitalHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: